AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 112 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,400,000 | -37.6% | 656,161 | -50.2% | 0.26% | -38.7% |
| Q2 2022 | $8,649,000 | +18.1% | 1,318,421 | +0.6% | 0.42% | +26.0% |
| Q1 2022 | $7,323,000 | +27.9% | 1,309,966 | +7.3% | 0.33% | +6.0% |
| Q4 2021 | $5,725,000 | -44.3% | 1,220,758 | -26.6% | 0.32% | -38.8% |
| Q3 2021 | $10,279,000 | -14.4% | 1,663,229 | -8.7% | 0.52% | +10.8% |
| Q2 2021 | $12,002,000 | – | 1,821,176 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PATHWAY CAPITAL MANAGEMENT, LP | 245,606 | $3,671,810 | 6.55% |
| AIGH Capital Management LLC | 695,358 | $10,395,602 | 3.42% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 638,360 | $9,544 | 2.08% |
| Kellner Capital, LLC | 100,016 | $1,495 | 1.74% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,464,807 | $21,898,865 | 1.70% |
| Worth Venture Partners, LLC | 170,925 | $2,555,329 | 1.51% |
| Birchview Capital, LP | 100,000 | $1,495 | 1.06% |
| BCK CAPITAL MANAGEMENT LP | 68,000 | $1,016,600 | 1.05% |
| WATER ISLAND CAPITAL LLC | 698,915 | $10,449 | 0.89% |
| EHP Funds Inc. | 292,043 | $4,366 | 0.82% |